Scholar Rock Holding Corporation | Mid-cap | Healthcare
$31.41
-2.73%
| Scholar Rock Holding Stock Comparison:
Scholar Rock Holding vs VertexScholar Rock Holding vs RegeneronScholar Rock Holding vs ModernaScholar Rock Holding vs BridgeBio PharmaScholar Rock Holding vs Blueprint MedicinesScholar Rock Holding vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 0
Operating Income -112.1M
Net Income -110.0M
EPS (Diluted) $-0.98

Balance Sheet Metrics

Total Assets 407.6M
Total Liabilities 95.2M
Shareholders Equity 312.3M
Debt to Equity 0.30

Cash Flow Metrics

Operating Cash Flow -66.4M
Free Cash Flow -78.9M

Revenue & Profitability Trend

Scholar Rock Holding Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i0033.2M18.8M15.4M
Cost of Goods Sold i-----
Gross Profit i-----
Gross Margin % i0.0%0.0%0.0%0.0%0.0%
Operating Expenses
Research & Development i184.6M121.9M124.4M108.5M74.1M
Selling, General & Administrative i67.5M49.4M43.1M40.3M28.2M
Other Operating Expenses i-----
Total Operating Expenses i252.1M171.3M167.6M148.7M102.3M
Operating Income i-252.1M-171.3M-134.4M-129.9M-86.9M
Operating Margin % i0.0%0.0%-404.8%-690.5%-564.0%
Non-Operating Items
Interest Income i-----
Interest Expense i-----
Other Non-Operating Income5.8M5.5M-132.0K-1.9M395.0K
Pre-tax Income i-246.3M-165.8M-134.5M-131.8M-86.5M
Income Tax i-----
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-246.3M-165.8M-134.5M-131.8M-86.5M
Net Margin % i0.0%0.0%-405.2%-700.5%-561.5%
Key Metrics
EBITDA i-250.1M-168.5M-131.4M-127.3M-85.4M
EPS (Basic) i$-2.47$-1.99$-2.26$-3.59$-2.81
EPS (Diluted) i$-2.47$-1.99$-2.26$-3.59$-2.81
Basic Shares Outstanding i9983810283347086596116563671183330734109
Diluted Shares Outstanding i9983810283347086596116563671183330734109

Income Statement Trend

Scholar Rock Holding Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i177.9M101.9M103.3M212.8M160.4M
Short-term Investments i259.4M178.1M212.1M40.2M180.7M
Accounts Receivable i----0
Inventory i-----
Other Current Assets--12.7M12.3M3.4M
Total Current Assets i451.2M288.2M328.0M265.3M344.4M
Non-Current Assets
Property, Plant & Equipment i25.9M21.7M28.8M34.9M37.6M
Goodwill i2.4M----
Intangible Assets i2.4M----
Long-term Investments-----
Other Non-Current Assets2.4M6.8M4.2M4.1M3.5M
Total Non-Current Assets i23.8M22.8M30.1M39.1M43.9M
Total Assets i474.9M311.0M358.2M304.4M388.3M
Liabilities
Current Liabilities
Accounts Payable i10.1M3.5M4.0M4.4M3.4M
Short-term Debt i5.8M8.7M7.9M9.0M5.4M
Current Portion of Long-term Debt-----
Other Current Liabilities-85.0K222.0K230.0K15.0K
Total Current Liabilities i46.9M32.7M36.4M64.3M42.6M
Non-Current Liabilities
Long-term Debt i59.4M53.1M61.5M68.1M51.8M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities----5.0K
Total Non-Current Liabilities i59.4M53.1M61.5M68.1M85.0M
Total Liabilities i106.3M85.8M97.9M132.4M127.5M
Equity
Common Stock i94.0K76.0K52.0K35.0K34.0K
Retained Earnings i-922.7M-676.4M-510.6M-376.1M-244.3M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i368.6M225.2M260.2M172.1M260.8M
Key Metrics
Total Debt i65.1M61.8M69.4M77.1M57.1M
Working Capital i404.2M255.5M291.6M201.0M301.8M

Balance Sheet Composition

Scholar Rock Holding Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-246.3M-165.8M-134.5M-131.8M-86.5M
Depreciation & Amortization i1.9M2.8M3.0M2.6M1.5M
Stock-Based Compensation i36.6M27.1M27.7M23.1M11.2M
Working Capital Changes i1.7M-11.2M-41.0M-23.6M9.5M
Operating Cash Flow i-200.5M-139.6M-137.2M-122.9M-61.9M
Investing Activities
Capital Expenditures i-98.0K-58.0K-1.1M-5.2M-4.1M
Acquisitions i-----
Investment Purchases i-293.2M-290.8M-300.6M-60.4M-200.1M
Investment Sales i217.2M332.0M130.0M200.0M140.7M
Investing Cash Flow i-76.1M41.1M-171.7M134.3M-63.5M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i--025.0M24.6M
Debt Repayment i-0-975.0K00
Financing Cash Flow i324.3M97.7M193.4M38.1M240.5M
Free Cash Flow i-201.0M-145.3M-133.8M-132.0M-64.4M
Net Change in Cash i47.7M-767.0K-115.5M49.5M115.2M

Cash Flow Trend

Scholar Rock Holding Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -13.07
Forward P/E -15.17
Price to Book 13.43
PEG Ratio -0.21

Profitability Ratios

Profit Margin 0.00%
Operating Margin 0.00%
Return on Equity -172.08%
Return on Assets -71.29%

Financial Health

Current Ratio 6.33
Debt to Equity 26.37
Beta 0.49

Per Share Data

EPS (TTM) $-2.92
Book Value per Share $2.43
Revenue per Share $0.00

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
srrk3.1B-13.0713.43-172.08%0.00%26.37
Vertex 100.4B27.855.8422.77%31.86%8.89
Regeneron 59.0B14.031.9415.34%31.37%9.04
Moderna 10.0B24.971.06-27.50%-94.31%7.88
BridgeBio Pharma 9.8B-17.82-5.5036.76%98.25%-1.04
Blueprint Medicines 8.4B-120.9924.43-47.71%-27.70%208.50

Financial data is updated regularly. All figures are in the company's reporting currency.